New England Journal of Medicine· 2017Q1
Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis
- 858citations
- Q1SCImago
- 2017year
Short summary
Adding pharmacomechanical thrombolysis to anticoagulation for acute proximal deep-vein thrombosis did not reduce the overall risk of post-thrombotic syndrome but did decrease moderate-to-severe cases (18% vs. 24%) and lowered symptom severity scores.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Internal Medicine
Internal MedicineMedicine